Abstract
Primary effusion lymphoma (PEL) harbors consistent infection by human herpesvirus-8, preferentially develops in immunodeficient patients and selectively localizes to the serous body cavities. Histogenetic analysis has suggested that PEL originates from post-germinal center, pre-terminally differentiated B cells sharing phenotypic features with plasma cells. Here we have investigated the expression status and functional integrity of the Met tyrosine kinase receptor and of its ligand hepatocyte growth factor (HGF). Thirteen PEL (nine cell lines and four primary specimens) were analyzed for Met and HGF expression and function by multiple assays. For comparison, a panel of 34 high grade B cell non-Hodgkin lymphomas (NHL) other than PEL was also investigated. Co-expression of Met and HGF was found in all PEL analyzed, whereas it was restricted to 1/34 B cell NHL other than PEL (P < 0.001; χ2 test). The Met protein expressed by PEL displays biochemical characteristics typical of Met expressed by other cell types and is capable of tyrosine autophosphorylation. By using a combination of immunological and biological assays, production and secretion of a functional HGF species was identified in all PEL cell lines analyzed. HGF stimulation of PEL cells rapidly induces Met tyrosine phosphorylation, demonstrating the functional integrity of the Met/HGF loop. Because of the well known mitogenic and motogenic properties of Met/HGF interactions, these data may bear implications for PEL growth and dissemination. Among B cell neoplasms, Met/HGF co-expression selectively clusters with PEL and, as demonstrated by previous studies, with multiple myeloma plasma cells, thus reinforcing the notion that PEL displays biologic similarities with tumors derived from late stages of B cell differentiation.
Similar content being viewed by others
References
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM . Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas New Engl J Med 1995 332: 1186–1191
Carbone A, Gaidano G . HHV-8-positive body cavity-based lymphoma: a novel lymphoma entity Br J Haematol 1997 97: 515–522
Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report Am J Clin Pathol 1999 111: (Suppl.1) S8–S12
Carbone A, Gloghini A, Vaccher E, Zagonel V, Pastore C, Dalla Palma C, Branz F, Saglio G, Volpe R, Tirelli U, Gaidano G . Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions Br J Haematol 1996 94: 533–543
Gaidano G, Pastore C, Gloghini A, Cusini M, Nomdedeu J, Volpe G, Capello D, Vaccher E, Bordes R, Tirelli U, Saglio G, Carbone A . Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia AIDS 1996 10: 941–949
Nador R, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM . Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus Blood 1996 88: 645–656
Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, Jaffe ES, Raffeld M . Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies Leukemia 1996 10: 1358–1362
Gessain A, Briere J, Angelin-Duclos C, Valensi F, Beral HM, Davi F, Nicola MA, Sudaka A, Fouchard N, Babarre J, Troussard X, Dulmet E, Audouin J, Diebold J, de Thé G . Human herpes virus 8 (Kaposi's sarcoma herpesvirus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas Leukemia 1997 11: 266–272
Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC . Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient New Engl J Med 1998 339: 444–449
Dotti G, Fiocchi R, Motta T, Facchinetti B, Chiodini B, Borleri GM, Gavazzeni G, Barbui T, Rambaldi A . Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8 Leukemia 1999 13: 664–670
Fais F, Gaidano G, Capello D, Gloghini A, Ghiotto F, Roncella S, Carbone A, Chiorazzi N, Ferrarini M . Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas Leukemia 1999 13: 1093–1099
Gaidano G, Capello D, Cilia AM, Gloghini A, Perin T, Quattrone S, Migliazza A, Lo Coco F, Saglio G, Ascoli V, Carbone A . Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis Genes Chrom Cancer 1999 24: 16–23
Gaidano G, Gloghini A, Gattei V, Rossi MF, Cilia AM, Godeas C, Degan M, Perin T, Canzonieri V, Aldinucci D, Saglio G, Carbone A, Pinto A . Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen Blood 1997 90: 4894–4900
Borset M, Lien E, Espevik T, Helseth E, Waage A . Sundan A. Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines J Biol Chem 1996 271: 24655–24661
Borset M . Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Hepatocyte growth factor and its receptor c-Met in multiple myeloma Blood 1996 88: 3998–4004
Giordano S, di Renzo MF, Olivero M, Mondino A, Zhen Z, Medico E, Comoglio PM . The c-met/HGF receptor in human tumours Eur J Cancer Prev 1992 1: (Suppl.3) 45–49
Maggiora P, Gambarotta G, Olivero M, Giordano S, Di Renzo MF, Comoglio PM . Control of invasive growth by the HGF receptor family J Cell Physiol 1997 173: 183–186
Jucker M, Gunther A, Gradl G, Fonatsch C, Krueger G, Diehl V, Tesch H . The met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma Leukemia Res 1994 18: 7–16
van der Woort R, Taher TEI, Keehnen RMJ, Smit L, Groenink M, Pals ST . Paracrine regulation of germinal center B cell adhesion through the c-Met-hepatocyte growth factor/scatter factor pathway J Exp Med 1997 185: 2121–2131
Weimar IS, de Jong D, Muller EJ, Nakamura T, van Goorp JMHH, de Gast GC, Gerritsen WR . Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via α4β1 and α5β1 integrins Blood 1997 89: 990–1000
Chirgadze DY, Hepple J, Byrd RA, Sowdhamini R, Blundell TL, Gherardi E . Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation FEBS Lett 1998 430: 126–129
Jiang W, Hiscox S, Matsumoto K, Nakamura T . Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer Crit Rev Oncol Hematol 1999 29: 209–248
Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y . In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences Blood 1995 86: 2708–2714
Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, Cesarman E . Establishment and characterization of primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein–Barr virus Blood 1996 88: 2648–2654
Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R . Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions Leukemia 1996 10: 1237–1240
Carbone A, Cilia AM, Gloghini A, Canzonieri V, Pastore C, Todesco M, Cozzi M, Perin T, Volpe R, Pinto A, Gaidano G . Establishment of HHV-8 positive and HHV-8 negative lymphoma cell lines from primary lymphomatous effusions Int J Cancer 1997 73: 562–569
Boshoff C, Gao S-J, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y . Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice Blood 1998 91: 1671–1679
Carbone A, Cilia AM, Gloghini A, Capello D, Todesco M, Quattrone S, Volpe R, Gaidano G . Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8 Br J Haematol 1998 102: 1081–1089
Drexler HG, Uphoff CC, Gaidano G, Carbone A . Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas) Leukemia 1998 12: 1507–1517
Uphoff CC, Habig S, Carbone A, Gaidano G, Drexler HG . HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas Leukemia 1998 12: 1806–1809
Kiwanuka J, Shiramizu B, Sandlund T, Barriga F, McManaway M, Novikovs L, Huber B, Magrath IT . The contribution of Burkitt's lymphoma cell lines to the understanding of the pathogenesis of Burkitt's lymphoma Cancer Rev 1988 10: 63–91
Drexler HG, Minowada J . History and classification of humanleukemia-lymphoma cell lines Leuk Lymphoma 1998 31: 305–316
Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G . Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors Proc Natl Acad Sci USA 1987 84: 6379–6383
Ercolani L, Florence B, Denaro M, Alexander M . Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene J Biol Chem 1988 263: 15335–15341
Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S . Molecular cloning and expression of human hepatocyte growth factor Nature 1989 342: 440–443
Prat M, Crepaldi T, Gandino L, Giordano S, Longati P, Comoglio P . C-terminal truncated forms of Met, the hepatocyte growth factor receptor Mol Cell Biol 1991 11: 5954–5962
Stoker ME, Gherardi E, Perryman M, Gray J . Scatter factor is a fibroblast-derived modulator of epithelial cell mobility Nature 1987 327: 239–242
Grano M, Galimi F, Zambonin G, Colucci S, Cottone E, Zambonin-Zallone A, Comoglio PM . Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro Proc Natl Acad Sci USA 1996 93: 7644–7648
Prat M, Crepaldi T, Pennacchietti S, Bussolino F, Comoglio PM . Agonistic monoclonal antibodies against Met receptor dissect the biological responses to HGF J Cell Sci 1998 111: 237–247
Cohen B, Yoakim M, Piwnica-Worms H, Roberts TM, Shaffhausen BS . Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity Proc Natl Acad Sci USA 1990 87: 4458–4462
Naidu YM, Rosen EM, Zitnick R, Goldberg I, Park M, Naujokas M, Polverini PJ, Nickoloff BJ . Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma Proc Natl Acad Sci USA 1994 91: 5281–5285
Maier JAM, Mariotti M, Albini A, Comi P, Prat M, Comoglio P, Soria MR . Over-expression of hepatocyte growth factor in human Kaposi's sarcoma Int J Cancer 1996 65: 168–172
Ferracini R . Olivero M, Di Renzo MF, Martano M, De Giovanni C, Nanni P, Basso G, Scotlandi K, Lollini P-L, Comoglio PM. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas Oncogene 1996 12: 1697–1705
Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M, Comoglio PM . The Met/HGF receptor is over-expressed in human osteosarcomas and is activated either by a paracrine or an autocrine circuit Oncogene 1995 10: 739–749
Yashiro M, Chung YS, Inoue T, Nishimura S, Matsuoka T, Fujihara T, Sowa M . Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination Int J Cancer 1996 67: 289–293
Acknowledgements
This work was supported by ISS, Programma nazionale sull'AIDS, Progetto ‘Patologia, clinica e terapia dell'AIDS’, Rome, Italy; by ‘Fondazione CRT’, Torino, Italy; and by ‘Fondazione Piera, Pietro e Giovanni Ferrero’, Alba, Italy. DC is being supported by a fellowship from AIRC, Milan, Italy.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Capello, D., Gaidano, G., Gallicchio, M. et al. The tyrosine kinase receptor Met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. Leukemia 14, 285–291 (2000). https://doi.org/10.1038/sj.leu.2401666
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401666
- Springer Nature Limited
Keywords
This article is cited by
-
The role of HGF/c-MET signaling pathway in lymphoma
Journal of Hematology & Oncology (2016)
-
High MET gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma
Diagnostic Pathology (2013)
-
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells
Breast Cancer Research (2010)
-
Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma
Laboratory Investigation (2010)
-
The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma
Leukemia (2003)